Sigma Advanced Systems adds ≈₹3,915 Cr of orders since July — the order book, not the quarter, is the story
Q2 FY27: revenue ₹417.07 Cr (+11.4% QoQ), PAT ₹48.60 Cr (+37.2%). Behind it, Rolls-Royce agreements of ≈₹5,400 Cr, three 155 mm export orders and a new Sri City plant.
MID-CAP
by market cap ≈ ₹14,471 Cr (Aug 27 close)
₹417.07 Cr
+11.43% QoQ, consolidated
₹48.60 Cr
+37.24% QoQ
19.73%
EBITDA ₹82.28 Cr, +35.06% QoQ
≈₹3,915 Cr
per the Nov 6 press release
₹763.65
Aug 27 · also the 52-week high
Sigma Advanced Systems — formerly Megasoft Limited, and now, per its own release, an aerospace and defence precision-engineering company with UK subsidiaries Nasmyth and Bromford — filed its Q2 FY27 results after market close on Friday, November 6. The quarter itself was solid: a second straight quarter of sequential revenue growth, with PAT also up QoQ. But the press release spends most of its length elsewhere, on ≈₹3,915 crore of new orders and long-term agreements won since July 2026, a completed UK acquisition, and a new Indian plant shipping its first parts. Measured against the ≈₹14,471 crore market cap computed at the August 27 close — the most recent price available to this report — the stated order wins are the larger fact.
Two quarters of sequential growth on a one-year-old revenue base
Q2 FY27: revenue ₹417.07 Cr, EBITDA ₹82.28 Cr, PAT ₹48.60 Cr
The board approved unaudited results for the quarter and half year ended September 30, 2026, at its meeting on November 6; the accompanying press release reports consolidated operational revenue of ₹417.07 Cr (up approximately 11.43% quarter-on-quarter from ₹374.27 Cr), consolidated operational EBITDA of ₹82.28 Cr at a 19.73% margin (up 35.06% from ₹61 Cr), profit after tax of ₹48.60 Cr (up approximately 37.24% from ₹35.41 Cr), and a gross margin of 66.32%.
Read:Margins expanded faster than revenue — EBITDA grew roughly three times as fast as the top line quarter-on-quarter. The filing reached the exchange after close (results at 16:54 IST, press release at 17:06 IST), so the market's response falls outside the price series available to this report.
Press release on Q2/H1 FY27 results, BSE filing, Nov 6, 2026For the first half of FY27 the company reports consolidated operational revenue of ₹791.34 Cr, EBITDA of ₹143.20 Cr and profit after tax of ₹84.01 Cr. Two things frame these numbers. First, the release itself cautions that H1 FY27 is not directly comparable with H1 FY26, citing the significant expansion in the company's scale of operations and changes in its business composition through FY26. Second, the standalone numbers show where the business actually sits: standalone Q2 revenue was ₹46.52 Cr with ₹14.88 Cr of net profit — meaning roughly nine-tenths of consolidated revenue is generated outside the standalone Indian entity, which is consistent with the release's description of Nasmyth and Bromford, its UK subsidiaries, as its presence in the global aerospace supply chain.
Q2 FY27 figures from the company's Nov 6 press release; earlier quarters from stored exchange results. FY26 Q1–Q2 record zero consolidated revenue; Q1 FY26's ₹136.23 Cr profit came against ₹187.46 Cr of total income, and Q4 FY26's ₹128.45 Cr net profit was booked with only ₹1.83 Cr of tax against ₹413.46 Cr of total income on ₹322.82 Cr of revenue.
The table is the context the headline numbers need. Four quarters ago this company reported zero consolidated revenue; the operating business producing ₹417 Cr a quarter today was assembled essentially within FY26 — which is exactly why management flags the year-on-year comparison as meaningless. Q1 FY26's ₹136.23 Cr net profit came on zero reported revenue, an other-income-driven outcome; Q4 FY26 sits differently, carrying ₹322.82 Cr of revenue alongside its ₹128.45 Cr profit — the stored results give the line items but not the narrative, so this report simply notes them rather than explains them. What the last two quarters do establish is a sequential pattern: revenue up 11.4%, EBITDA up 35.1%, PAT up 37.2% quarter-on-quarter, on a revenue base that has been building since Q3 FY26, about a year ago.
₹3,915 crore of wins since July, and where the number comes from
≈₹973.64 Cr order for 155 mm Base Bleed Units from a NATO customer
Sigma secured an export order valued at USD 102.23 million (approximately ₹973.64 Cr, per the results release) from a NATO customer for the manufacture and supply of Base Bleed Units for 155 mm artillery ammunition, to be executed over 12 months. The company's October 26 release describes the multi-year order as strengthening its position in the artillery ammunition manufacturing ecosystem and advancing its strategy of vertical integration.
Read:This is the second-largest of the three ammunition export orders disclosed since July — the July 27 order (≈₹1,013 Cr) was larger — and at the stated rupee value would on its own equal more than two quarters of current standalone revenue, though execution runs through the consolidated manufacturing footprint.
Press release — ₹973 Cr Base Bleed Units order, BSE filing, Oct 26, 2026Exclusive MoU with Munitions India for 155 mm course-correction fuses
Sigma signed an exclusive memorandum of understanding with Munitions India Limited for the integration, indigenous manufacturing and supply of its 155 mm artillery course-correction fuses. The October 14 release frames the collaboration as building next-generation indigenous capabilities and supporting Indian military programmes.
Read:No order value is attached to the MoU in the filings available here — it is a capability and channel agreement rather than booked business, and should be read as such until a purchase order follows.
Press release — MoU with Munitions India Limited, BSE filing, Oct 14, 2026The results release itemises the ≈₹3,915 Cr of wins since July 2026. Four orders are listed: a USD 104.9 million (≈₹1,013 Cr) export order dated July 27 from a North American customer for 155 mm base bleed artillery shell bodies, executable over 6 to 12 months; the USD 102.23 million (≈₹973.64 Cr) Base Bleed Units order above; a USD 19.7 million (≈₹174 Cr) order dated October 21 from a North American NATO customer for 155 mm artillery ammunition subsystems, scheduled for execution by Q2 2027 — which that day's release called the fifth 155 mm milestone since May 2026; and ≈₹155 Cr of Government of India orders dated August 17, won with Indrajaal Autonomous Defense Systems, for the Indrajaal Ranger anti-drone patrol vehicle. Those four sum to ≈₹2,316 Cr. The release also reports that Bromford Precision Solutions — the Leicester-based maker of aero-engine rings that Sigma finished acquiring at an enterprise value of about GBP 11.89 million (≈₹153 Cr) — secured a further long-term Rolls-Royce agreement of nearly GBP 125 million (≈₹1,600 Cr) within weeks of closing. Adding that agreement to the four orders gives ≈₹3,916 Cr, which matches the company's ≈₹3,915 Cr figure almost exactly — so the headline number appears to include the Bromford agreement, an inference the release's own arithmetic supports. With the GBP 300 million (≈₹3,800 Cr) agreement signed in April 2026, the two Rolls-Royce long-term agreements now total nearly GBP 425 million (≈₹5,400 Cr). Against the ≈₹14,471 Cr market cap at the August 27 close, the ₹3,915 Cr of stated wins amount to roughly 27% — with the caveat that long-term agreements are frameworks the release says strengthen order book and revenue visibility, not quarterly revenue.
A UK acquisition, an Indian plant, and ₹460 crore of fresh equity
Sri City aerospace facility begins production
Sigma announced that its dedicated aerospace manufacturing facility at Sri City, Andhra Pradesh — 75,000 sq ft, with 100,000 annual machining hours of capacity and the capability to expand to 300,000 — produced its first batch of precision-machined aerospace components, replicating UK manufacturing capability in India. The November 6 release adds that the facility commenced operations following the transfer of work from the company's UK operations and has delivered its first batch to Nasmyth's UK customers.
Read:This is the physical half of the India–UK integration the company describes: UK-held customer relationships and work packages, with manufacturing shifted to Indian capacity. The September 11 investor plant visit at Sri City suggests the company is actively showing the site to the market.
Media release — Sri City facility begins production, BSE filing, Sep 10, 2026Two more items from the release round out the build-out. Nasmyth, the UK subsidiary, received the Innovation Award at the 2026 Global Boeing Supplier Summit in Seattle for its R&D work. And the growth is being funded with fresh equity: in August 2026 the company completed a preferential allotment of ₹460 Cr at ₹347 per share, with participation from mutual funds and other investors, the proceeds supporting growth initiatives including acquisitions. The shareholding patterns show the dilution arriving: between the pattern dated June 30 and the one dated July 27, total shares outstanding rose from 17.62 crore to 18.95 crore — an increase of about 1.33 crore shares, which is almost exactly what a ₹460 Cr issue at ₹347 per share would create — while the promoter holding stayed at 12.55 crore shares, taking the promoter stake from 71.22% to 66.24%. (The release dates completion to August; the pattern is labelled as of July 27 — the filings available here don't resolve that gap.) Institutional holdings otherwise remain negligible: 2.45 lakh shares with FIIs and about 34,000 with DIIs as of the July pattern.
This has been a productive quarter for Sigma. The Bromford Precision acquisition gives us a stronger footing with global aerospace OEMs, and the second Rolls-Royce agreement came within weeks of it closing.
— Sunil Kalidindi, CEO and Executive Director — results press release, Nov 6, 2026
Over the 60 sessions in the series the stock rose from ₹458.70 on June 4 to ₹763.65 on August 27 — a gain of about 66% — and that final close is also the 52-week high, standing roughly 445% above the 52-week low of ₹140.10 set on March 16, 2026. The honest caveat: the series stops more than two months before the results. How the market received the October orders, the November 6 numbers, or the filings discussed below is not measurable from the data in this report, and the ≈₹14,471 Cr market cap used throughout is likewise dated August 27.
The filings that would change this picture
Fund-raise
Which instrument — FPO, preferential allotment, rights issue, private placement or QIP — and at what size (up to the approved ₹3,000 Cr cap) and price the company pursues, and how that interacts with the 66.24% promoter holding.
Order execution
Conversion of the stated orders into revenue: ≈₹1,013 Cr over 6–12 months from July 2026, ≈₹973.64 Cr over 12 months from October, and ≈₹174 Cr scheduled by Q2 2027.
Shareholding pattern
The next quarterly pattern — promoter percentage after the ₹460 Cr allotment settles, and whether the mutual funds the release says participated begin to show up in the negligible DII line.
What the November 6 filings establish is a company two quarters into an operating history at this scale, growing sequentially on every headline line, and claiming ≈₹3,915 crore of new orders and agreements since July — a figure whose components the release itemises and whose arithmetic checks out against the individual disclosures. The Rolls-Royce agreements, the Bromford acquisition and the Sri City facility describe a coherent strategy: UK customer relationships, Indian manufacturing cost.
The open items are narrower than they first appear. The three director resignations were explained in the same filings — all citing personal time constraints rather than disagreement with the board — and the board already approved raising up to ₹3,000 Cr, leaving only the instrument, size within that cap and pricing undecided. What remains genuinely open is execution: whether the ≈₹3,915 Cr of new orders converts into revenue at the pace the last two quarters suggest, and the revenue base being grown is, by the company's own statement, too new to compare year-on-year. The data suggests a business whose stated order book now runs well ahead of its reported revenue — the next two quarters of execution will show which of the two is the better guide.
Informational and educational content only. Not investment advice.